Summit Therapeutics
SMMT
#1294
Rank
$14.01 B
Marketcap
$19.00
Share price
3.15%
Change (1 day)
850.00%
Change (1 year)

Summit Therapeutics (SMMT) - Cash on Hand

Cash on Hand as of September 2024 : $0.48 Billion USD

According to Summit Therapeutics 's latest financial reports the company has $0.48 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Summit Therapeutics - Cash on Hand chart (from 2020 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.18 B-46.58%
2022-12-31$0.34 B385.59%
2021-12-31$71.79 M8.09%
2020-12-31$66.41 M
2019-01-31$46.2 M14.72%
2018-01-31$40.27 M-8.13%
2017-01-31$43.84 M32.55%
2016-01-31$33.07 M29.71%
2015-01-31$25.5 M361.59%
2014-01-31$5.52 M-34.48%
2013-01-31$8.43 M64.65%
2012-01-31$5.12 M-37.1%
2011-01-31$8.14 M-47.66%
2010-01-31$15.55 M178.05%
2009-01-31$5.59 M-85.99%
2008-01-31$39.93 M-43.31%
2007-01-31$70.43 M75.59%
2006-01-31$40.11 M-20.15%
2005-01-31$50.23 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$1.19 B 146.13%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$0.24 B-49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$97.69 M-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA